Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma Journal Article

  

Authors:	Gerecitano, J.; Gounder, S.; Teruya-Feldstein, J.; Arcila, M.; Ogilvie, S.; Gonzalez, C.; Lin, D.; Zheng, J.; Zhang, Z.; McDonald, A.; Mulligan, G.; O'Connor, O. A.
Article Title:	Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma
Keywords:	adult; cancer survival; protein expression; treatment outcome; aged; aged, 80 and over; middle aged; protein array analysis; unclassified drug; major clinical study; outcome assessment; follow up; letter; protein function; ki 67 antigen; biological marker; protein bcl 2; progression free survival; bortezomib; proteasome; boronic acids; pyrazines; vascular cell adhesion molecule 1; neoplasm proteins; tumor markers, biological; recurrence; transcription factor rela; caspase; protein p53; survivin; carcinogenesis; nonhodgkin lymphoma; lymphoma, non-hodgkin; cyclin dependent kinase inhibitor 1b; ny eso 1 antigen; mcl1; protein mcl 1; drug response; cancer relapse; down regulation; upregulation; protein bcl 6; tissue microarray; cyclin dependent kinase inhibitor 1a; cyclin d1; interferon regulatory factor 4; non-hodgkin lymphoma; flice inhibitory protein; cancer prognosis; cdkn1b; cflar; proteasome subunit alpha5; proteasome subunit beta1
Journal Title:	British Journal of Haematology
Volume:	158
Issue:	2
ISSN:	0007-1048
Publisher:	John Wiley & Sons
Date Published:	2012-07-01
Start Page:	290
End Page:	292
Language:	English
DOI:	10.1111/j.1365-2141.2012.09137.x
PROVIDER:	scopus
PUBMED:	22533368
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84863469158&partnerID=40&md5=7a02aa5ee065b777df7d368ca770e085
Notes:	--- - "Export Date: 1 August 2012" - "CODEN: BJHEA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/31865